Hologic, Inc. (HOLX): Price and Financial Metrics
Hologic, Inc. (HOLX)
Today's Latest Price: $57.86 USD
Updated Jul 2 4:00pm
Add HOLX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 132 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
HOLX Stock Summary
- HOLX has a market capitalization of $14,717,723,646 -- more than approximately 89.24% of US stocks.
- HOLX's went public 30.29 years ago, making it older than 84.66% of listed US stocks we're tracking.
- Over the past twelve months, HOLX has reported earnings growth of 413.75%, putting it ahead of 96.67% of US stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Hologic Inc are WAB, FMC, IFF, PRGO, and ENTG.
- HOLX's SEC filings can be seen here. And to visit Hologic Inc's official web site, go to www.hologic.com.
HOLX Stock Price Chart Technical Analysis Charts
HOLX Price/Volume Stats
| Current price | $57.86 | 52-week high | $58.72 |
| Prev. close | $56.97 | 52-week low | $26.49 |
| Day low | $57.54 | Volume | 3,008,756 |
| Day high | $58.72 | Avg. volume | 2,795,436 |
| 50-day MA | $52.29 | Dividend yield | N/A |
| 200-day MA | $48.97 | Market Cap | 14.94B |
Hologic, Inc. (HOLX) Company Bio
Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.
HOLX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $57.86 | $23.93 | -55% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Hologic Inc. To summarize, we found that Hologic Inc ranked in the 28th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Hologic Inc, consider:
- Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than merely 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 7. This value is greater than just 21.45% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -56% |
| 1% | -56% |
| 2% | -55% |
| 3% | -55% |
| 4% | -54% |
| 5% | -54% |
ABT, ESMC, BHC, CNMD, and IONS can be thought of as valuation peers to HOLX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...